Discover

PRFX
PRF Technologies Ltd.
1.20
1 x 1.10
2 x 1.19
bid
ask
+
0.05
4.35%
100 @ 07:58 AM
1.13 -0.07 (5.83%)
Ytd-62.62%
1y-84.00%
1.13
day range
1.21
1.13
52 week range
96.00
Open1.13Prev Close1.15Low1.13High1.21Mkt Cap1000.00K
Vol68.52KAvg Vol929.20KEPSN/AP/EN/AForward P/E-0.37
Beta1.05Short Ratio0.02Inst. Own6.58%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg1.55200-d Avg3.321yr Est12.00
Earning
DateForEstimateReportedSurprisesurprise %
2024-08-152024-060-9.6N/AN/A
2024-05-152024-030-65.27N/AN/A
2024-02-292023-120N/AN/AN/A
2023-11-152023-09011.52N/AN/A
2023-05-152023-030-52.79N/AN/A
2023-03-162022-120-69.59N/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2024-10-24Maxim GroupDowngradeBuyHold
2024-06-26Maxim GroupUpgradeBuyBuy
Profile
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29UBS Group AG6.50K28.97K0.74%
2024-09-29Two Sigma Securities, LLC4.31K19.21K0.49%
2024-09-29HRT Financial LP3.58K15.95K0.41%
2024-09-29Osaic Holdings Inc192.00856.000.02%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Fidelity NASDAQ Composite Index Fund80.00356.000.01%
Split
SplitDate
1 : 52026-02-06
1 : 42024-11-21
1 : 62024-09-09
1 : 102023-07-03